An experimental Chinese coronavirus vaccine under development by the Institute of Medical Biology at the Chinese Academy of Medical Sciences has been shown to be safe in an early clinical trial, researchers said.
In a Phase 1 trial involving 191 healthy participants between the ages of 18 and 59, vaccination with the group’s experimental vaccine showed no serious side effects, its researchers said in an article on Tuesday’s server. preprint medRxiv prior to peer review.
The most common side effects reported by trial participants were mild pain, mild fatigue, and redness, itching, and swelling at the injection site.
The candidate also induced an immune response.
“All of the data obtained in this trial support the safety and immunogenicity of this inactivated vaccine and are encouraging for further studies on its effectiveness in the future,” the document said.
China has inoculated hundreds of thousands of essential workers and other groups considered to be at high risk with other vaccines, even as clinical trials were not fully completed, raising safety concerns among experts.
China has at least four experimental vaccines in the final stages of clinical trials.
(Except for the title, this story was not edited by GalacticGaming staff and is posted from a syndicated feed.)